- Home
- ENR vs JANX Comparison
ENR vs JANX Comparison
Compare ENR & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENR
- JANX
- Stock Information
- Founded
- ENR 2015
- JANX 2017
- Country
- ENR United States
- JANX United States
- Employees
- ENR N/A
- JANX N/A
- Industry
- ENR Industrial Machinery/Components
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- ENR Miscellaneous
- JANX Health Care
- Exchange
- ENR Nasdaq
- JANX Nasdaq
- Market Cap
- ENR 1.6B
- JANX 1.4B
- IPO Year
- ENR N/A
- JANX 2021
- Fundamental
- Price
- ENR $29.01
- JANX $24.71
- Analyst Decision
- ENR Hold
- JANX Strong Buy
- Analyst Count
- ENR 7
- JANX 10
- Target Price
- ENR $31.43
- JANX $79.50
- AVG Volume (30 Days)
- ENR 717.7K
- JANX 645.3K
- Earning Date
- ENR 08-04-2025
- JANX 11-05-2025
- Dividend Yield
- ENR 4.10%
- JANX N/A
- EPS Growth
- ENR 2300.45
- JANX N/A
- EPS
- ENR 3.41
- JANX N/A
- Revenue
- ENR $2,925,600,000.00
- JANX $439,000.00
- Revenue This Year
- ENR $3.12
- JANX N/A
- Revenue Next Year
- ENR $2.92
- JANX $591.60
- P/E Ratio
- ENR $8.57
- JANX N/A
- Revenue Growth
- ENR 1.15
- JANX N/A
- 52 Week Low
- ENR $19.70
- JANX $21.97
- 52 Week High
- ENR $39.52
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- ENR 60.81
- JANX 53.67
- Support Level
- ENR $28.12
- JANX $23.62
- Resistance Level
- ENR $29.41
- JANX $25.35
- Average True Range (ATR)
- ENR 0.64
- JANX 1.10
- MACD
- ENR -0.08
- JANX 0.19
- Stochastic Oscillator
- ENR 84.13
- JANX 72.33
About ENR Energizer Holdings Inc.
Energizer Holdings Inc makes and distributes household batteries, specialty batteries, and lighting products. Energizer offers batteries using lithium, alkaline, carbon-zinc, nickel-metal hydride, zinc-air, and silver oxide technologies. These products are sold under the Energizer, Rayovac, Varta and Eveready brands at performance and premium price segments. It also offers auto care products in the appearance, fragrance, performance, and air conditioning recharge product categories. The company operates in two geographical segments: Americas and International, of which the majority of its revenue is derived from the America. It has two product segments: Batteries & Lights and Auto Care. It earns maximum revenue from Batteries & Lights segment.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.